Healthcare
PAG commits $250m to Chinese pharma company
PAG Asia has invested $250 million in Shaanxi–based Bicon Pharmaceutical Holdings, becoming its largest investor, according to a statement released by the pharma company on Tuesday.
Australian venture capitalists face commercialization obstacles
Entrepreneurs are brimming with ideas but Australia’s venture capital firms don’t have the capital to convert innovation into products. Government support has so far been piecemeal
Mandarin Capital achieves 3x return on Euticals exit
Mandarin Capital Partners has sold more than half of its stake in Italian pharmaceutical ingredient maker Euticals, netting a return of three times of its initial investment - a record for Chinese private equity outbound investment.
Burrill & Company expands into Taiwan
Burrill & Company, a global financial services firm which focuses on the life sciences industry, is opening an office in Taiwan. Marietta Wu has been promoted to managing director and will lead operations.
High India pharma valuations price PE firms out of the market
With strategic investors drawn to India’s rapidly growing pharma sector, private equity players must either go niche or get out
IDG, Accel back GlamSmile Asia with $7m
IDG Capital Partners and Accel Partners have jointly invested $7 million for a 31.4% stake in GlamSmile Asia via a capital increase and the provision of replacement capital.
FGPI gives $41m cash boost to Aptuit Laurus
Fidelity Growth Partners India (FGPI), the India-focused the private equity arm of Fidelity Worldwide Investment, has invested INR2 billion ($40.6 million) in pharma company Aptuit Laurus.
Unison nears $650m Showa Yakuhin Kako buyout - sources
Japanese private equity firm Unison Capital is reportedly in the final round of bidding for Showa Yakuhin Kako, a drug producer backed by Tokio Marine Capital.
Elara Capital to launch India-focused healthcare fund
Elara Capital, a UK-based financial services company, is in talks with a counterpart in Dubai with a view to launching a private equity fund that will target healthcare investments in Asia and Africa. India will be a particular area of focus given Elara’s...
Singapore Medical to receive $4.5m from Kendall Court
Singapore Medical Group (SMG) will receive a SGD$5.6 million ($4.5 million) investment from Kendall Court, representing the private equity’s first foray into the healthcare sector.
Vivo takes US healthcare into China
Tria is a US-based company that manufactures a hair removal laser designed for use in the home or in the office. Approved by the Federal Drug Administration and already sold in the US, Canada, the UK, Japan and Korea, the device is now being primed for...
Olympus invests $100m in DM Healthcare, India Value Fund exits
Olympus Capital Asia Investments has invested more than INR5 billion ($100 million) for a minority stake in DM Healthcare, in a deal which enabled existing investor India Value Fund to exit the company.
CrystalGenomics receives $2.6m from VC-backed fund
South Korea-based CrystalGenomics has secured KRW3 billion ($2.6 Million) through a private placement to the Korea Seoul Life Science Fund (KSLSF).
GIC-backed Fortis Healthcare India bolts on Fortis International
Fortis Healthcare, the listed India-based chain of hospitals backed by Government of Singapore Investment Corp. (GIC), has completed the bolt-on acquisition of Fortis Healthcare International for $665 million.
Adveq set to increase China investment to $550m
China will remain the focal point of international institution investors for the next 10 years, according to Adveq Management. The private equity fund-offunds manager plans to increase its investment in China to RMB3.5 billion ($554 million) over the...
Canaan Partners closes ninth fund at $600m
Canaan Partners, the venture capital firm that focuses on the US, India and Israel, has closed its ninth fund at $600 million. The new vehicle, which received commitments from both new and existing LPs, takes the firm’s total assets under management to...
Indian medical equipment company seeks PE funding
Sutures India, a Bangalore-based medical equipment manufacturer is seeking $25-40 million from private equity investors. The funds would be used for expansion and other purposes, but as yet no mandates have been given investment banks.
Vivo Ventures closes seventh fund at $375m
Vivo Ventures, the US and Greater China-focused healthcare investment firm, has closed its seventh fund at $375 million. The firm now has more than $1 billion under management.
Warburg Pincus ups stake in China Biologic Products
Warburg Pincus Private Equity has upped its stake in human plasma collection company China Biologic Products (CBPO), in its tenth purchase of shares in the company this year.
BVP India invests in Indian dialysis clinics
Many entrepreneurs within growth-stage firms claim to live and breathe their business propositions. One company founder, Kamah Shah, takes this adage to the next level, however, as his reliance on kidney dialysis machines sees him undergoing the treatment...
Matrix injects $4m in Waterlife India
Matrix Partners India has invested INR220 million ($4.2 million) in drinking water supplier Waterlife India.
Bain, TPG, TA circle VC-backed Trivitron
Bain Capital, TPG and TA Associates are reportedly weighing up the possibility of investing for a 10-12% stake in Indian medical device provider Trivitron Healthcare.
Archer, Ironbridge achieve iNova exit
It may have taken longer than expected, but Archer Capital and Ironbridge Capital have finally exited Australian portfolio company iNova Pharmaceuticals to a Canadian trade buyer two years after launching an auction for the company. A healthy return on...
J.P. Morgan gets green light for $1b RMB fund
J.P. Morgan Asset Management has reportedly won approval from the Beijing government to launch a $1 billion renminbi-denominated fund.